232 related articles for article (PubMed ID: 15170765)
21. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp).
Bryson CL; Au DH; Young B; McDonell MB; Fihn SD
Med Care; 2007 Jun; 45(6):497-504. PubMed ID: 17515776
[TBL] [Abstract][Full Text] [Related]
22. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period.
Krigsman K; Moen J; Nilsson JL; Ring L
J Clin Pharm Ther; 2007 Dec; 32(6):603-11. PubMed ID: 18021338
[TBL] [Abstract][Full Text] [Related]
23. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
24. Prescribing and monitoring clozapine in Christchurch.
McKean A; Vella-Brincat J; Begg E
Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
26. Medication refill logistics and refill adherence in HIV.
Gross R; Zhang Y; Grossberg R
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):789-93. PubMed ID: 15880515
[TBL] [Abstract][Full Text] [Related]
27. A gap analysis approach to assess patient persistence with glaucoma medication.
Lee PP; Walt JG; Chiang TH; Guckian A; Keener J
Am J Ophthalmol; 2007 Oct; 144(4):520-4. PubMed ID: 17692273
[TBL] [Abstract][Full Text] [Related]
28. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
[TBL] [Abstract][Full Text] [Related]
29. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication.
Andersson K; Melander A; Svensson C; Lind O; Nilsson JL
Eur J Public Health; 2005 Dec; 15(6):621-6. PubMed ID: 16126746
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring of patients on risperidone depot.
Nesvåg R; Tanum L
Nord J Psychiatry; 2005; 59(1):51-5. PubMed ID: 16195099
[TBL] [Abstract][Full Text] [Related]
31. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication.
Krigsman K; Nilsson JL; Ring L
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1120-8. PubMed ID: 17566142
[TBL] [Abstract][Full Text] [Related]
32. Use of prescribed and non-prescribed medication for dyspepsia.
Krol N; Muris JW; Schattenberg G; Grol R; Wensing M
Scand J Prim Health Care; 2004 Sep; 22(3):163-7. PubMed ID: 15370793
[TBL] [Abstract][Full Text] [Related]
33. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
[TBL] [Abstract][Full Text] [Related]
34. Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis.
Heres S; Hamann J; Mendel R; Wickelmaier F; Pajonk FG; Leucht S; Kissling W
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1987-93. PubMed ID: 18948163
[TBL] [Abstract][Full Text] [Related]
35. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
36. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
[TBL] [Abstract][Full Text] [Related]
37. Adherence and persistence with fluticasone propionate/salmeterol combination therapy.
Bender BG; Pedan A; Varasteh LT
J Allergy Clin Immunol; 2006 Oct; 118(4):899-904. PubMed ID: 17030244
[TBL] [Abstract][Full Text] [Related]
38. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Bitter I; Treuer T; Dyachkova Y; Martenyi F; McBride M; Ungvari GS
Eur Neuropsychopharmacol; 2008 Mar; 18(3):170-80. PubMed ID: 17884390
[TBL] [Abstract][Full Text] [Related]
40. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
Kalsekar I; Sheehan C; Peak A
Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
